About Prof. Mateo Aboy
Prof. Mateo Aboy joined the LML (University of Cambridge) in 2015. His research includes evidence-based IP studies of precision medicine and information age inventions (biomarkers, diagnostics, and algorithm-based inventions), medical device regulation (AI/ML SaMD), biomarker qualification, information security, and data privacy law. Mateo pursues research at the interface between engineering, law, and management sciences.
He is currently researching the status of precision medicine inventions as patentable subject matter. A core component of this work is an in-depth quantitative analysis of trends in patenting activity and patent examination following key United States Supreme Court decisions affecting biomedical, biotech, and computer-implemented inventions (Myriad, Mayo, Alice), coupled with a comparative study of European patent law. This work sheds light on the implications of legal doctrine for prosecution strategies, licensing and innovation. Additionally, he pursues research on AI/ML SaMDs, medical device law, regulatory science, biomarker qualification, and data privacy law. This work has resulted in several Nature Biotechnology publications.
Mateo’s multidisciplinary background includes a combination of intellectual property, engineering, regulatory science, and management experience. He holds degrees in engineering and data science (BS, MS, MPhil, PhD), law (LLB), international management (MBA), as well as professional registrations as a Professional Chartered Engineer (EU/ES COIT), Certified Licensing Professional (CLP), Patent Practitioner licensed to practice in patent cases before the United States Patent Office (USPTO), Lead Implementer of Information Security Management Systems-ISMS (ISO 27001), Lead Auditor of Medical Device Quality Management Systems (ISO 13485), and Lead Implementer of Privacy Information Management Systems - PIMS (ISO 27701).
Behind the paper "How does the emerging patent case law in the US and Europe affect precision medicine?"